VivoSim Labs (FRA:4OR) Gross Profit: €0.13 Mil (TTM As of Dec. 2025)


FRA:4OR VivoSim Labs Inc FRA:4OR
38 GF Score
Price €3.49
GF Value €10.31
! 4 Warning Signs
View Full Analysis

What is VivoSim Labs Gross Profit?

VivoSim Labs FRA:4OR 38 Gross Profit is €0.13 Mil as of Dec. 2025. GuruFocus rates FRA:4OR with a GF Score™ of 38/100 and a GF Value™ of €10.31. The stock has 4 warning signs investors should review.

VivoSim Labs's gross profit for the three months ended in Dec. 2025 was €0.02 Mil. VivoSim Labs's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was €0.13 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. VivoSim Labs's gross profit for the three months ended in Dec. 2025 was €0.02 Mil. VivoSim Labs's Revenue for the three months ended in Dec. 2025 was €0.02 Mil. Therefore, VivoSim Labs's Gross Margin % for the quarter that ended in Dec. 2025 was N/A%.

VivoSim Labs had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of VivoSim Labs was 96.53%. The lowest was 77.40%. And the median was 84.41%.


VivoSim Labs  (FRA:4OR) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

VivoSim Labs had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage


VivoSim Labs Gross Profit Related Terms


VivoSim Labs Gross Profit Historical Data

* Premium members only.

The historical data trend for VivoSim Labs's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VivoSim Labs Gross Profit Chart

VivoSim Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.36 0.35 0.10 0.13

VivoSim Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.05 0.03 0.02 0.02

FRA:4OR vs SLXN, CDT, CLDI: Gross Profit Comparison

For the Biotechnology subindustry, VivoSim Labs's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VivoSim Labs Gross Profit vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's Gross Profit distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's Gross Profit falls into.


FRA:4OR
38GF Score
VivoSim Labs Inc FRA:4OR
Gross Profit is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VivoSim Labs Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

VivoSim Labs's Gross Profit for the fiscal year that ended in Mar. 2025 is calculated as

Gross Profit (A: Mar. 2025 )=Revenue - Cost of Goods Sold
=0.133 - 0.004
=0.13

VivoSim Labs's Gross Profit for the quarter that ended in Dec. 2025 is calculated as

Gross Profit (Q: Dec. 2025 )=Revenue - Cost of Goods Sold
=0.022 - 0
=0.02

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.13 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

VivoSim Labs's Gross Margin % for the quarter that ended in Dec. 2025 is calculated as

Gross Margin % (Q: Dec. 2025 )=Gross Profit (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.02 / 0.022
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of €0.13 Mil mean?
VivoSim Labs (FRA:4OR) has a Gross Profit of €0.13 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on VivoSim Labs and its competitors.
Is VivoSim Labs' Gross Profit too high?
VivoSim Labs' current Gross Profit is €0.13 Mil. Overall, VivoSim Labs has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does VivoSim Labs' Gross Profit compare to SLXN and CDT?
VivoSim Labs' Gross Profit of €0.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on VivoSim Labs and its competitors. VivoSim Labs's current Gross Profit is €0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VivoSim Labs stock overvalued right now?
VivoSim Labs (FRA:4OR) has a current Gross Profit of €0.13 Mil. The stock's GF Value™ is €10.31, compared to a current price of €3.49 — trading 66.1% below its estimated fair value. The current Gross Profit is €0.13 Mil. VivoSim Labs' overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For VivoSim Labs (FRA:4OR), the current Gross Profit is €0.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is VivoSim Labs (FRA:4OR) Overvalued in 2026?

Based on GuruFocus' analysis, VivoSim Labs stock appears to be undervalued. The current stock price of €3.49 is trading 66.1% below its estimated GF Value™ of €10.31.

Key valuation signals for FRA:4OR:

  • Gross Profit: €0.13 Mil
  • GF Value™: €10.31 vs. price of €3.49 (66.1% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the FRA:4OR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


VivoSim Labs Business Description

Other Exchanges VIVS:USA
Address 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
38GF Score

Get the complete analysis for FRA:4OR

Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49
Price
€10.31
GF Value